High Fidelity Restriction Endonucleases
US-2024352437-A1 · Oct 24, 2024 · US
US9512413B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9512413-B2 |
| Application number | US-201314403949-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 31, 2013 |
| Priority date | May 31, 2012 |
| Publication date | Dec 6, 2016 |
| Grant date | Dec 6, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to isolated polypeptides having organophosphorous hydrolase activity, and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
Opening claim text (preview).
The invention claimed is: 1. A method for removing an organophosphorous compound, comprising contacting the organophosphorous compound with a polypeptide having organophosphorous hydrolase activity and comprising an amino acid sequence having at least 90% sequence identity to the amino acid sequence of amino acids 12 to 314 of SEQ ID NO: 2 to thereby remove the organophosphorous compound. 2. The method of claim 1 , wherein the polypeptide has at least 94% sequence identity to the amino acid sequence of amino acids 12 to 314 of SEQ ID NO: 2. 3. The method of claim 1 , wherein the polypeptide has at least 95% sequence identity to the amino acid sequence of amino acids 12 to 314 of SEQ ID NO: 2. 4. The method of claim 1 , wherein the polypeptide has at least 96% sequence identity to the amino acid sequence of amino acids 12 to 314 of SEQ ID NO: 2. 5. The method of claim 1 , wherein the polypeptide has at least 97% sequence identity to the amino acid sequence of amino acids 12 to 314 of SEQ ID NO: 2. 6. The method of claim 1 , wherein the polypeptide has at least 98% sequence identity to the amino acid sequence of amino acids 12 to 314 of SEQ ID NO: 2. 7. The method of claim 1 , wherein the polypeptide has at least 99% sequence identity to the amino acid sequence of amino acids 12 to 314 of SEQ ID NO: 2. 8. The method of claim 1 , wherein the organophosphorous compound is a nerve gas, toxin or pesticide. 9. A method for decontaminating an area or a device contaminated with an organophosphorous compound, comprising contacting the area or device with a polypeptide having organophosphorous hydrolase activity and comprising an amino acid sequence having at least 90% sequence identity to the amino acid sequence of amino acids 12 to 314 of SEQ ID NO: 2 to thereby decontaminate the area or device. 10. The method of claim 9 , wherein the polypeptide has at least 99% sequence identity to the amino acid sequence of amino acids 12 to 314 of SEQ ID NO: 2. 11. The method of claim 9 , wherein the organophosphorous compound is a nerve gas, toxin or pesticide.
Pesticides, e.g. insecticides, herbicides, fungicides or nematocides · CPC title
by biological methods, i.e. processes using enzymes or microorganisms · CPC title
Diisopropyl-fluorophosphatase (3.1.8.2) · CPC title
containing nitrogen or phosphorus · CPC title
acting on ester bonds (3.1) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.